PEDRO
Patient Experience Data in Radiation Oncology
Rekrutierend
NCT-Nummer:
NCT05224297
Studienbeginn:
Oktober 2020
Letztes Update:
10.03.2022
Wirkstoff:
-
Indikation (Clinical Trials):
Neoplasms
Geschlecht:
Alle
Altersgruppe:
Erwachsene (18+)
Phase:
-
Sponsor:
Medical University of Vienna
Collaborator:
-
Kontakt
Gerd Heilemann, PhD
Kontakt:
Phone: 004314040072710
E-Mail: gerd.heilemann@meduniwien.ac.at» Kontaktdaten anzeigen
Brief Summary:
The project is part of the overarching goal of improving patient-centric radiation oncology.
This pilot project aims to develop an instrument that can be used to collect clinically
relevant patient-reported outcome data on adverse effects during and after RT. This
real-world evidence (RWE) database will be the basis to monitor and evaluate future
technological developments, combination treatments (e.g. radioimmunotherapy, etc.), or
changes in treatment protocols. The pseudonymized data will be linked to data in the
oncological information system and dosimetric data from the treatment planning system. In
this way, they represent a basic building block of patient-oriented development of clinical
radiotherapy.
Inclusion Criteria:
- all patients receiving external beam radiotherapy
Exclusion Criteria:
- unable to independently answer questionnaires on radiation-induced side effects
Primary outcome:
1. radiation-related side effects (Time Frame - during radiotherapy and after (up until 5 years))
- breast
- thorax
- skin
- abdomen
- skull
- head and neck
- pelvis male
- pelvis female
- extremities
- external beam photon therapy:
Patients receive external beam photon therapy for different tumor locations (groups).
Quelle: ClinicalTrials.gov
Sie können folgenden Inhalt einem Kollegen empfehlen:
"Patient Experience Data in Radiation Oncology"
Bitte tragen Sie auch die Absenderdaten vollständig ein, damit Sie der Empfänger erkennen kann.
Die mit (*) gekennzeichneten Angaben müssen eingetragen werden!
